Millstone Evans Group’s Pfizer PFE Stock Holding History

Millstone Evans Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$150K	Buy	6,243 +71	+1%	+$1.86K	0.08%	187
2026 Q1	$173K	Sell	6,172 -26	-0.4%	-$692	0.1%	157
2025 Q4	$154K	Buy	6,198 +286	+5%	+$7.21K	0.09%	171
2025 Q3	$151K	Buy	5,912 +116	+2%	+$2.86K	0.1%	158
2025 Q2	$140K	Sell	5,796 -1,230	-18%	-$28.7K	0.1%	160
2025 Q1	$178K	Sell	7,026 -1,162	-14%	-$30.4K	0.12%	128
2024 Q4	$217K	Buy	+8,188	New	+$222K	0.15%	111

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Millstone Evans Group's PFE Position: Q2 2026 in Review

Millstone Evans Group increased its Pfizer (PFE) stake by 1.2% in Q2 2026, buying an estimated $1.86K and bringing the position to 6,243 shares worth $150K. The position accounts for 0.08% of the portfolio, ranked #187.

Millstone Evans Group first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $217K in Q4 2024. 2,429 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Millstone Evans Group held 6,243 shares of Pfizer worth $150K as of Q2 2026.
Millstone Evans Group bought 71 Pfizer shares in Q2 2026, an estimated $1.86K.
Pfizer made up 0.08% of Millstone Evans Group's portfolio in Q2 2026, its #187 holding.
Millstone Evans Group first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Millstone Evans Group's Pfizer position peaked at $217K in Q4 2024.
2,429 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Millstone Evans Group's 13F filing for Q2 2026, filed 11 Aug 2026.